We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

100 hedge funds and large institutions have $486M invested in Lumos Pharma, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $296M → $486M (+$190M)

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

27% more call options, than puts

Call options by funds: $59.5M | Put options by funds: $47M

9% more funds holding

Funds holding: 92 → 100 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 32

Holders
100
Holders Change
+8
Holders Change %
+8.7%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
27
Reduced
32
Closed
15
Calls
$59.5M
Puts
$47M
Net Calls
+$12.5M
Net Calls Change
-$1.85M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$5.24M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$4.92M
3
BFA
BlackRock Fund Advisors
California
+$2.56M
4
Wells Fargo
Wells Fargo
California
+$2.51M
5
Barclays
Barclays
United Kingdom
+$2.29M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$37.9M
2
PC
PointState Capital
New York
-$20.6M
3
HT
HAP Trading
New York
-$6.16M
4
Stifel Financial
Stifel Financial
Missouri
-$4.1M
5
DFO
Duquesne Family Office
New York
-$3.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
DFO
101
Duquesne Family Office
New York
– -$3.91M -20,278 Closed
DCM
102
Driehaus Capital Management
Illinois
– -$1.4M -7,256 Closed
CWG
103
C WorldWide Group
Denmark
– -$1.41M -7,000 Closed
ERSOT
104
Employees Retirement System of Texas
Texas
– -$964K -5,000 Closed
Millennium Management
105
Millennium Management
New York
– -$660K -3,422 Closed
CCM
106
Coe Capital Management
Illinois
– -$428K -2,222 Closed
FAAS
107
First Allied Advisory Services
California
– -$231K -1,206 Closed
SCM
108
Stevens Capital Management
Pennsylvania
– -$214K -1,111 Closed
SO
109
STRS Ohio
Ohio
– -$135K -700 Closed
QT
110
Quantbot Technologies
New York
– -$88K -459 Closed
JG
111
Jefferies Group
New York
– -$92.6K -311 Closed
TRCT
112
Tower Research Capital (TRC)
New York
– -$50K -261 Closed
BNP Paribas Financial Markets
113
BNP Paribas Financial Markets
France
– -$27.7K -144 Closed
Bank of Montreal
114
Bank of Montreal
Ontario, Canada
– -$19K -99 Closed
WAM
115
Wolverine Asset Management
Illinois
– -$14K -78 Closed
1 2 3 4
5

LUMO Hedge Fund Activity: Q4 2014 in Review

100 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2014, worth a combined $486M — up 64% from $296M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new LUMO positions and 15 closed out — a net gain of 9 holders — while 27 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $5.24M. The largest seller was Fidelity Investments, cutting an estimated $37.9M.

  • 100 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2014, up from 92 in Q3 2014.
  • Funds reported $486M of Lumos Pharma, Inc. Common Stock stock for Q4 2014, up 64% quarter-over-quarter.
  • 24 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2014 and 15 closed out, a net change of +9 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2014 was BlackRock Institutional Trust, an estimated $5.24M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2014 was Fidelity Investments, an estimated $37.9M sold.

Based on aggregated 13F filings for Q4 2014.